Estimates of bladder cancer burden attributable to high fasting plasma glucose: Findings of the Global Burden of Disease Study 2019

被引:1
|
作者
Wu, Ying [1 ]
Deng, Yujiao [2 ]
Dai, Zhijun [3 ,4 ]
Ma, Yubo [1 ]
Lyu, Lijuan [4 ]
Lei, Chen [5 ]
Zheng, Yi [2 ]
Li, Yizhen [4 ]
Wang, Ziming [1 ,7 ]
Gao, Jie [2 ,6 ]
机构
[1] Xi An Jiao Tong Univ, Dept Urol, Affiliated Hosp 2, Xian, Peoples R China
[2] Xi An Jiao Tong Univ, Dept Nephrol, Affiliated Hosp 2, Xian, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Breast Surg, Hangzhou, Peoples R China
[4] Xi An Jiao Tong Univ, Dept Oncol, Affiliated Hosp 2, Xian, Peoples R China
[5] Ningxia Med Univ, Dept Endocrinol, Gen Hosp, Yinchuan, Peoples R China
[6] Xi An Jiao Tong Univ, Dept Nephrol, Affiliated Hosp 2, Xian 710004, Peoples R China
[7] Xi An Jiao Tong Univ, Dept Urol, Affiliated Hosp 2, Xian 710004, Peoples R China
来源
CANCER MEDICINE | 2023年 / 12卷 / 15期
关键词
bladder cancer; DALY; death; high fasting plasma glucose; DIABETES-MELLITUS; CIGARETTE-SMOKING; RISK; PREVALENCE; COUNTRIES; CONSUMPTION; MIDDLE;
D O I
10.1002/cam4.6219
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: High fasting plasma glucose (FPG) has been listed as one of the risk factors for bladder cancer. We here estimated the global, regional, and national levels of bladder cancer burden attributable to high FPG from 1990 to 2019. Methods: Bladder cancer data attributable to high FPG were extracted from the Global Burden of Disease Study 2019, and analyzed by age, sex, year, and location. Age-standardized rates were utilized to evaluate the burden between different populations. The temporal trend of the burden was estimated through the Joinpoint analysis. Results: In 2019, high FPG contributed to 22,823.33 (95% uncertainty interval [UI], 4694.88-48,962.26) deaths and 399,654.91 (95% UI, 81,609.35-865,890.95) disability-adjusted life years (DALYs) of bladder cancer globally. Since 1990, the global age-standardized death and DALY rates of bladder cancer attributable to high FPG increased apparently by 39.18% and 41.48%, respectively. During the last 30 years, high FPG-related age-standardized death and DALY rates of bladder cancer have increased in all countries. In 2019, Central Europe showed the greatest high FPG-related age-standardized death and DALY rates of bladder cancer, but Andean Latin America had the lowest rates. Nationally, Lebanon showed the greatest high FPG-related age-standardized death and DALY rates of bladder cancer in 2019. High FPG-attributable deaths and DALYs of bladder cancer were more considerable among males and older people. Countries with high SDI showed higher levels of age-standardized death and DALY rates of bladder cancer due to high FPG and presented remarkable upward trends in rates in the last 30 years. Conclusions: Globally, the high FPG-associated bladder cancer burden has remarkably increased in all countries, and showed a higher level among countries with higher SDI. Monitoring FPG levels among patients with bladder cancer is critical to lower the corresponding burden.
引用
下载
收藏
页码:16469 / 16481
页数:13
相关论文
共 50 条
  • [21] Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019
    Safiri, Saeid
    Nejadghaderi, Seyed Aria
    Karamzad, Nahid
    Kaufman, Jay S.
    Carson-Chahhoud, Kristin
    Bragazzi, Nicola Luig
    Sullman, Mark J. M.
    Beyranvand, Mohammad Reza
    Mansournia, Mohammad Ali
    Almasi-Hashiani, Amir
    Collins, Gary S.
    Kolahi, Ali-Asghar
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [22] Burden of disease attributable to Risk Factors in Brazil: an analysis of national and subnational estimates from the 2019 Global Burden of Disease study
    Malta, Deborah Carvalho
    Felisbino-Mendes, Mariana Santos
    Machado, Isis Eloah
    Veloso, Guilherme Augusto
    Gomes, Crizian Saar
    Caldeira Brant, Luisa Campos
    Pinho Ribeiro, Antonio Luiz
    Vasconcelos de Oliveira, Patricia Pereira
    Flor, Luisa Sorio
    Gakidou, Emmanuela
    ENGENHARIA AGRICOLA, 2022, 55
  • [23] The Global, Regional, and National Uterine Cancer Burden Attributable to High BMI from 1990 to 2019: A Systematic Analysis of the Global Burden of Disease Study 2019
    Liu, Jingchun
    Wang, Haoyu
    Wang, Zhi
    Han, Wuyue
    Hong, Li
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (05)
  • [24] Global Burden of Respiratory Diseases Attributable to Ambient Particulate Matter Pollution: Findings From the Global Burden of Disease Study 2019
    Wu, Ying
    Song, Ping
    Lin, Shuai
    Peng, Ling
    Li, Yizhen
    Deng, Yujiao
    Deng, Xinyue
    Lou, Weiyang
    Yang, Si
    Zheng, Yi
    Xiang, Dong
    Hu, Jingjing
    Zhu, Yuyao
    Wang, Meng
    Zhai, Zhen
    Zhang, Dai
    Dai, Zhijun
    Gao, Jie
    FRONTIERS IN PUBLIC HEALTH, 2021, 9
  • [25] Global burden of cardiovascular disease attributable to smoking, 1990-2019: an analysis of the 2019 Global Burden of Disease Study
    Minhas, Abdul Mannan Khan
    Sedhom, Ramy
    Jean, Estelle D.
    Shapiro, Michael D.
    Panza, Julio A.
    Alam, Mahboob
    Virani, Salim S.
    Ballantyne, Christie M.
    Abramov, Dmitry
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2024, 31 (09) : 1123 - 1131
  • [26] The global, regional, and national disease burden of breast cancer attributable to tobacco from 1990 to 2019: a global burden of disease study
    Qiusheng Guo
    Yunyan Lu
    Weiguo Liu
    Gaochen Lan
    Tian Lan
    BMC Public Health, 24
  • [27] The global, regional, and national disease burden of breast cancer attributable to tobacco from 1990 to 2019: a global burden of disease study
    Guo, Qiusheng
    Lu, Yunyan
    Liu, Weiguo
    Lan, Gaochen
    Lan, Tian
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [28] Emerging patterns and trends in global cancer burden attributable to metabolic factors, based on the Global Burden of Disease Study 2019
    Zhang, Yan
    Ding, Yuwei
    Zhu, Ning
    Mi, Mi
    Lu, Yier
    Zheng, Jia
    Weng, Shanshan
    Yuan, Ying
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [29] The global burden of ischemic heart disease attributed to high fasting plasma glucose: Data from 1990 to 2019
    Shen, Nirui
    Liu, Jin
    Wang, Yan
    Qiu, Yuanjie
    Li, Danyang
    Wang, Qingting
    Chai, Limin
    Chen, Yuqian
    Hu, Huizhong
    Li, Manxiang
    HELIYON, 2024, 10 (05)
  • [30] The global burden and associated factors of ovarian cancer in 1990–2019: findings from the Global Burden of Disease Study 2019
    Shiwen Zhang
    Chen Cheng
    Zejian Lin
    Linzi Xiao
    Xin Su
    Lu Zheng
    Yingjun Mu
    Minqi Liao
    Ruiqing Ouyang
    Wanlin Li
    Junrong Ma
    Jun Cai
    Lu Liu
    Donghong Wang
    Fangfang Zeng
    Jun Liu
    BMC Public Health, 22